BullFrog AI Holdings, Inc. (BFRGW) company profile

BullFrog AI Holdings, Inc. operates as a digital healthcare and artificial intelligence company focused on advancing biopharmaceutical development. The company utilizes its proprietary bfLEAP™ artificial intelligence and machine learning platform, derived from technology developed at The Johns Hopkins University Applied Physics Laboratory, to analyze complex pre-clinical and clinical data sets. Its business model centers on contract services, providing fee-for-service analytics to biopharmaceutical firms and other organizations, as well as collaborative arrangements and the internal development of acquired drug assets targeting various oncology and liver disease indications.

The company operates primarily through BullFrog AI Holdings, Inc., alongside its subsidiaries BullFrog AI, Inc. and BullFrog AI Management, LLC. It holds exclusive intellectual property licenses with institutions such as The Johns Hopkins University and George Washington University. BullFrog AI maintains its principal executive offices and headquarters in Gaithersburg, Maryland.

Summary of the business section of BullFrog AI's latest annual report, written by StockData.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“The initial public offering price of our Units is $6.50 per Unit.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

“of December 31, 2025, the Company had 9 full-time employees, including its Chief Executive Officer, and 8 part-time employees, advisors,”